Adjuvant Therapy for Potentially Immunotherapy-Responsive Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT07772557 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07772557
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2031-12-31
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.